ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Jarle Vaage
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vaage, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Vaage, J.
Related Collections
Right arrow Myocardial protection

Ann Thorac Surg 2003;75:1252
© 2003 The Society of Thoracic Surgeons

Invited commentary

Jarle Vaage, MD

Department of Thoracic Surgery, Karolinska Hospital, Stockholm 17176, Sweden

e-mail: jarle.vaage@ks.se

The first 20% of the full text of this article appears below.

Experimentally preconditioning is the most powerful mode of protection against ischemia-reperfusion injury known. In cardiac surgery with cardiopulmonary bypass and cardioplegia, most studies conclude that preconditioning improves myocardial preservation [1]. Only a few investigations have studied ischemic preconditioning in off-pump coronary artery bypass grafting (OPCAB) [2, 3], and the present study is an important contribution to this line of research. It is a timely and well-conducted study, which is the only one conducted on OPCAB with multivessel disease and . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The Society of Thoracic Surgeons.